Radicicol inhibits tyrosine phosphorylation of the mitotic Src substrate sam68 and retards subsequent exit from mitosis of Src-transformed cells

Cell Growth and Differentiation

Volumn 7, Issue 11, 1996, Pages 1487-1499

  Pillay, Indiren ^a   Nakano, Hirofumi ^b   Sharma, Sreenath V ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERBIMYCIN A; PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RADICICOL; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; FLOW CYTOMETRY; IMMUNOBLOTTING; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BENZOQUINONES; CELL LINE, TRANSFORMED; ENZYME INHIBITORS; LACTAMS, MACROCYCLIC; LACTONES; MACROLIDES; MICE; MITOSIS; NOCODAZOLE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); QUINONES; RNA-BINDING PROTEINS; SRC HOMOLOGY DOMAINS; TIME FACTORS; TYROSINE;

ANIMALIA;

EID: 0029910050     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Pardee, A. B. G1 events and regulation of cell proliferation. Science (Washington DC), 246: 603-608, 1989.
2. Shalloway, D., Bagrodia, S., Chackalaparampil, I., Shenoy, S., Lin, P. H., and Taylor, S. J. c-Src and mitosis. Ciba Found. Symp., 170:248-265, 1992.
3. c-src during fibroblast mitosis. Cell, 52: 801-810, 1988.
4. Taylor, S. J., and Shalloway, D. Src and the control of cell division. Bioessays, 78:9-11, 1996.
5. Taylor, S. J., and Shalloway, D. The cell cycle and c-Src. Curr. Opin. Genet. Dev., 3: 26-34, 1993.
6. cdc2-associated protein kinase. Cell, 57: 775-786, 1989.
7. c-src at the sites phosphorylated during fibroblast mitosis. Cell, 57. 763-774, 1989.
8. c-src during mitosis. Proc. Natl. Acad. Sci. USA, 89: 7237-7241, 1992.
9. c-src: implications for regulation. Science (Washington DC), 237: 1431-1434, 1986.
10. c-src mutated in the carboxy-terminal regulatory domain. Cell, 49: 83-91, 1987.
11. Hunter, T. A tail of two src's: Mutatis mutandis. Cell, 49:1-4, 1987.
12. c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell, 49: 65-73, 1987.
13. c-src. Cell, 49: 75-82, 1987.
14. c-src. Nature (Lond.), 349: 172-175, 1991.
15. c-src with polyoma virus middle-T antigan abrogating mitosis-specific activation. Nature (Lond.), 350: 431-433, 1991.
16. Shalloway, D., Bagrodia, S., Chackalaparampil, I., Shenoy, S., Lin, P.-H., and Taylor, S. J. c-src and mitosis. Ciba Found. Symp., 170: 248-275, 1992.
17. Liu, X. Q., and Pawson, T. Biochemistry of the src protein-tyrosine kinase: regulation by SH2 and SH3 domains. In: C. W. Bardin (ed.), Recent Progress in Hormone Research, Vol. 49. San Diego: Academic Press, Inc., 1994.
18. Courtneidge, S., Fumagalli, S., Koegl, M., Superti-Furga, G., and Twamley-Stein, G. M. The src family of protein tyrosine kinases: regulation and functions. Dev. Suppl., pp. 57-64, 1993.
19. Courtneidge, S. A., and Fumagalli, S. A mitotic function for src? Trends Cell Sol., 4: 345-350, 1994.
20. Fumagalli, S., Totty, N. F., Hsuan, J. J., and Courtneidge, S. A target for Src in mitosis. Nature (Lond.), 368: 871-874, 1994.
21. Taylor, S. J., and Shalloway, D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature (Lond.), 368: 867-871, 1994.
22. Mackintosh, C., and Mackintosh, R. W. Inhibitors of protein kinases and phosphatases. Trends Biochem. Sci., 79: 444-448, 1994.
23. Powis, G. Signalling pathways as targets for anticancer drug development. Pharmacol. Then, 62: 57-95, 1994.
24. Delmotte, P., and Delmotte-Plaquee, J. A new antifungal substance of fungal origin. Nature (Lond.), 171: 344-, 1958.
25. McCapra, F., Scott, A. I., Delmotte, P., Delmotte-Plaquee, J., and Bhacca, N. S. The constitution of monorden, an antibiotic with tranquilizer action. Tetrahedron Lett., 15: 869-875, 1964.
26. Mirrington, R. N., Ritchie, E., Shoppee, C. W., Taylor, W. C., and Sternhell, S. The constitution of Radicicol. Tetrahedron Lett., 7: 365-370, 1964.
27. Oikawa, T., Ito, H., Ashino, H., Toi, M., Tominaga, T., Morita, I., and Murota, S. Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis. Eur. J. Pharmacol., 241: 221-227, 1993.
28. Kwon, H. J., Yoshida, M., Abe, K., Horinouchi, S., and Beppu, T. Radicicol, an agent inducing the reversal of transformed phenotypes of src-transformed fibroblasts. Biosci. Biotech. Biochem., 56: 538-539, 1992.
29. v-src protein kinase both in vivo and in vitro by radicicol. Cancer Res., 52: 6926-6930, 1992.
30. Hall, T. J., Schaeublin, M., and Missbach, M. Evidence that c-src is involved in the process of osteoclastic bone resorption. Biochem. Biophys. Res. Commun., 199: 1237-1244, 1994.
31. Zhao, J-F., Nakano, H., and Sharma, S. V. Suppression of ras and mos transformation by radicicol. Oncogene, 11: 161-173, 1995.
32. Kwon, H.-J., Yoshida, M., Muroya, K., Hattori, S., Nishida, E., Fukui, Y., Beppu, T., and Horinouchi, S. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the Ras-GTP complex. J. Biochem., 118: 221-228, 1995.
33. src direct stable association with tyrosine phosphorylated proteins p130 and p110. EMBO J., 10: 1689-1698, 1991.
34. Wong, G., Muller, O., Clark, R., Conroy, L., Moran, M., Polakis, P., and McCormick, F. Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. Cell, 69: 551-558, 1992.
35. Lock, P., Fumagalli, S., Polakis, P., McCormick, F., and Courtneidge, S. The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein. Cell, 84: 23-24, 1996.
36. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. Oncogenes and signal transduction. Cell (published erratum appears in Cell 65: following 914], 64: 281-302, 1991.
37. src substrate. Mol. Cell. Biol., 11: 5113-5124, 1991.
38. src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell Biol., 120: 1417-1426, 1993.
39. 14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism. FEBS Lett., 340: 155-158, 1994.
40. Murakami, Y., Mizuno, S., Hori, M., and Uehara, Y. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts. Cancer Res., 48: 1587-1590, 1988.
41. Uehara, Y., and Fukazawa, H. Use of selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol., 201: 370-379, 1991.
42. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell, 64: 693-702, 1991.
43. Ayer, W. A., Lee, S. P., Tsuneda, A., and Hiratsuka, Y. The isolation, identification, and bioassay of the antifungal metabolites produced by Monocillium nordinii. Can. J. Microbiol., 26: 766-773, 1980.
44. Pawson, T. Protein modules and signalling networks. Nature (Lond.), 373: 573-580, 1995.
45. Weng, Z., Thomas, S. M., Rickles, R. J., Taylor, J. A., Brauer, A. W., Seidel-Dugan, C., Michael, W. M., Dreyfuss, G., and Brugge, J. Identification of src, fyn, and lyn SH3-binding proteins: implications for a function of SH3 domains. Mol. Cell. Biol., 14: 4509-4521, 1994.
46. Yen, A., Soong, S., Kwon, H. J., Yoshida, M., Beppu, T., and Varvayanis, S. Enhanced cell differentiation when RB is hypophosphorylated and down-regulated by radicicol, a SRC-kinase inhibitor. Exp. Cell Res., 214: 163-171, 1994.
47. c-src and increases its protein-tyrosine kinase activity. Mol. Cell. Biol., 8: 3345-3356, 1988.
48. Kypta, R. M., Goldberg, Y., Ulug, E. T., and Courtneidge, S. A. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell, 62: 481-492, 1990.
49. June, C. H., Fletcher, M. C., Ledbetter, J. A., Schieven, G. L., Siegel, J. N., Philips, A. F., and Samelson, L. E. Inhibition of tyrosine phosphorylation prevent T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA, 87: 7722-7726, 1990.
50. Lyall, R. M., Zilberstein, A., Gazit, A., Gilon, C., Levitzki, A., and Schlessinger, J. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J. Biol. Chem., 264: 14503-14509, 1989.
51. Richard, S., Yu, D. Y., Blumer, K. J., Hausladen, D., Olszowy, M. W., Connelly, P. A., and Shaw, A. S. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, grb2, and phospholipase c γ-1. Mol. Cell. Biol., 15: 186-197, 1995.
52. Wang, L. L., Richard, S., and Shaw, A. S. p62 association with RNA is regulated by tyrosine phosphorylation. J. Biol. Chem., 270: 2010-2013, 1995.
53. Taylor, S. J., Anafi, M., Pawson, T., and Shalloway, D. Functional interaction between c-Src and its mitotic target, Sam 68. J. Biol. Chem., 270: 10120-10124, 1995.
54. Zieve, G. W., Turnbull, D., Mullins, J. M., and McIntosh, J. R. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Exp. Cell. Res., 126: 397-405, 1980.
55. Nüsse, M., and Egner, H. J. Can nocodazole, an inhibitor of microtubule formation, be used to synchronize mammalian cells? Cell Tissue Kinet., 17: 13-23, 1984.
56. Pillay, I., and Sharma, S. V. In vivo and in vitro serine/threonine phosphorylations of epidermal growth factor receptor upon entry into the cell cycle. Cell Growth & Differ., 6: 39-49, 1995.
57. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
58. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
59. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, pp. 471-506. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
60. Lee, S-L, Stevens, J., Wang, W. W., and Lanzillo, J. J. A liquid gelatin blocking reagent for Western blotting with chemiluminescent detection. BioTechniques, 17: 60-62, 1994.
61. Tesfaigzi, J., Smith-Harrison, W., and Carlson, D. M. A simple method for reusing Western blots on PVDF membranes. BioTechniques, 17: 268-269, 1994.
62. Cleveland, D. W., Fischer, S. G., Kirschner, M. W., and Laemmli, U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol. Chem., 252: 1102-1106, 1977.